Neuphoria Therapeutics (NEUP) Non-cash Items (2024 - 2026)
Neuphoria Therapeutics (NEUP) reported Non-cash Items of $77285.0 for Q1 2026, up 73.28% year-over-year from $44601.0 in Q1 2025, and up 7.03% on a QoQ basis from $72210.0 in Q4 2025.
Neuphoria Therapeutics (NEUP) has 3 years of Non-cash Items data on file, last reported at $77285.0 in Q1 2026.
- Quarterly Non-cash Items rose 73.28% year-over-year to $77285.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77285.0 (up 73.28% YoY) and the FY2025 annual result came in at $64485.0, down 35.51% from the prior year.
- Non-cash Items advanced to $77285.0 in Q1 2026 per NEUP's latest filing, from $72210.0 in the prior quarter.
- Across five years, Non-cash Items topped out at $100000.0 in Q2 2024 and bottomed at $44601.0 in Q1 2025.
- The 3-year median for Non-cash Items is $74747.5 (2025), against an average of $77935.4.
- The widest annual swing landed in 2025, when Non-cash Items slumped 35.51%; it then surged 73.28% in 2026.
- Tracing NEUP's Non-cash Items over 3 years: stood at $100000.0 in 2024, then decreased by 27.79% to $72210.0 in 2025, then grew by 7.03% to $77285.0 in 2026.
- Per Business Quant, the three latest NEUP Non-cash Items figures stand at $77285.0 (Q1 2026), $72210.0 (Q4 2025), and $64902.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Neuphoria Therapeutics | 28.35 Mn | 8.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77,285.00 |
| Mar 31, 2026 | 77,285.00 |
| Dec 31, 2025 | 400,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 453,013.00 |
| Sep 30, 2025 | 453,013.00 |
| Jun 30, 2025 | 64,485.00 |
| Jun 30, 2025 | 64,485.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |